- Mali Bulletin des prix - décembre 2016
- 30th High-level Meeting of Heads of UN Missions in West Africa
- OCHA Humanitarian Bulletin, October - November 2016 EN/FR
Appeals & Funding
- 2017 Sahel - Overview of humanitarian needs and requirements EN FR
- Plan de Réponse Humanitaire, Janvier - Décembre 2017
- Aperçu des besoins humanitaires 2017
- FTS Mali Archive
- Mali | Data - The World Bank
- Mali Ministère de la Santé et de l'Hygiène
- UNHCR Opération Mali Portail de partage de l'Information
- Sahel Online Reporting System
- IOM Humanitarian Compendium
- OCHA Mali
- Mission multidimensionnelle intégrée des Nations Unies pour la stabilisation au Mali (MINUSMA)
- OCHA Sahel Crisis
- Food Security Cluster: Mali
- HRW Report: Mali Events of 2016
Polio this week as of 1 June 2016
Last week, health ministers from around the world met in Geneva for the annual World Health Assembly (WHA). Among other public health topics, delegates reviewed and discussed the latest global polio epidemiology and reaffirmed commitment to ending transmission in the remaining polio reservoirs. Read more
This week, health ministers from around the world are convening in Geneva for the annual World Health Assembly (WHA). Among other public health topics, delegates will review and discuss the latest global polio epidemiology. The GPEI has set up a WHA-specific polio website, with the key documents that are guiding discussions.
By the end of 2015, strong progress continued towards each of the Endgame Plan’s four objectives. The world has never been closer to eradicating polio, with fewer cases in fewer areas of fewer countries than at any time in the past. The virus is now more geographically constrained than at any point in history. As the GPEI enters 2016, it is more important than ever to redouble efforts to eradicate poliovirus in every corner of the globe.
From the 17 April to the 1 May, 155 countries and territories participated in the historic trivalent to bivalent oral polio vaccine switch, withdrawing the type two component of the vaccine to protect future generations against circulating vaccine derived polioviruses. Track the switch live.
The World Health Assembly (WHA) Report on Poliomyelitis has been published. The report summarises the status against the Polio Endgame Plan and Resolution WHA68.3, adopted by the WHA in May 2015.
Canada has announced a contribution of $ 40 million Canadian Dollars to support the eradication of polio in Pakistan over the next three years.
The third Outbreak Response Assessment in Madagascar found that the surveillance system is not yet strong enough to conclude that polio transmission has been interrupted. Thirty-nine high-risk districts have been identified to receive focused attention.
One new cases of wild poliovirus type 1 (WPV1) were reported in the past week, in Nawzad district of Hilmand province, with onset of paralysis on 23 January. The total number of WPV1 cases for 2016 remains 2, compared to 1 reported for 2015 at this point last year.
No new WPV1 environmental positive samples were reported in the past week. The most recent environmental positive samples were collected on 27 December 2015 - one in Jalalabad in Nangarhar province and the second in the city of Kabul.
As we enter February 2016, GPEI bids farewell to Hamid Jafari, the former director of GPEI, whose tenure has seen the removal of Nigeria from the list of polio-endemic countries, certification of the eradication of wild poliovirus type 2, and the lowest number of cases reported in the fewest number of places in any one year. GPEI welcomes Michel Zaffran, former coordinator of the WHO Expanded Programme on Immunization (EPI), as its new director, as we enter a pivotal part of the Endgame Plan.
On 20 October, the Strategic Advisory Group of Experts on immunization (SAGE) confirmed that the globally coordinated withdrawal of the type 2 component in oral polio vaccine (OPV) should occur in April 2016, specifically in a window from 17 April to 1 May. Countries should intensify their preparatory efforts to switch from trivalent OPV to bivalent OPV to meet this timeline.
In Lao Democratic People’s Republic a circulating vaccine-derived poliovirus type 1 (cVDPV1) outbreak has been confirmed, with one case, an eight year old boy who had onset of paralysis on 7 September. Outbreaks of cVDPVs can arise in areas of low population immunity, emphasizing the importance of strong vaccination coverage. Learn more about VDPVs.
Afghanistan became the final polio-endemic country to introduce the inactivated polio vaccine on 30 September as part of the biggest globally synchronized vaccine introduction in history.
This week, the Independent Monitoring Board is meeting in London to assess progress towards polio eradication and to make recommendations for the coming months. The report is expected to be published in the next few weeks.
The week, WHO removed Nigeria from the list of polio-endemic countries following all samples in the polio laboratory being tested negative for wild poliovirus for a whole year following the most recent case on 24 July 2014. This is the first time that Nigeria has interrupted transmission of wild poliovirus, bringing the country and the African region closer than ever to being certified polio-free. More.
Declaration further milestone for globally-coordinated vaccine switch in 2016
20 September, Bali – In an important step towards a polio-free world, the Global Commission for the Certification of Poliomyelitis Eradication (GCC) today concluded that wild poliovirus type 2 (WPV2) has been eradicated worldwide. The GCC reached its conclusion after reviewing formal documentation submitted by Member States, global poliovirus laboratory network and surveillance systems. The last detected WPV2 dates to 1999, from Aligarh, northern India.
- Pakistan launched a nationwide polio campaign this week to vaccinate more than 35 million children in 163 districts of the country. Approximately 200,000 polio workers are participating in the polio campaign, during which Vitamin A will also be distributed.
A case of vaccine-derived poliovirus type 2 (VDPV2) has been reported with onset of paralysis on 20 July 2015 in Bamako city, Mali. The virus was isolated from a 19-month old boy of Guinean nationality. The closest genetic match to this case is from a case from Kankan, Guinea, with onset of paralysis on 30 August 2014. The genetic changes suggest that the cVDPV2 has been circulating for more than 12 months. Discussions are currently ongoing with national health authorities to plan and implement an urgent outbreak response.